MazenNoureddinMDMHSc

PubMed

• Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort.
  Khoudari, G., Singh, A., Noureddin, M., Fritze, D., Lopez, R., Asaad, I., Lawitz, E., Poordad, F., Kowdley, K. V., Alkhouri, N.> ;World journal of hepatology. 2019 Nov 22
• Pathogenesis of NASH: The Impact of Multiple Pathways.
  Noureddin, M., Sanyal, A. J.> ;Current hepatology reports. 2019 Aug 6
• Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment.
  Alkhouri, N., Lawitz, E., Noureddin, M.> ;Hepatology communications. 2019 May 8
• Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis.
  Han, MAT.,Altayar, O.,Hamdeh, S.,Takyar, V.,Rotman, Y.,Etzion, O.,Lefebvre, E.,Safadi, R.,Ratziu, V.,Prokop, L. J.,Murad, M. H.,Noureddin, M.> ;Clin. Gastroenterol. Hepatol.. 2018 Jun 19
• Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.
  Sundaram, V., Wu, T., Klein, A. S., Noureddin, M., Kim, I. K., Todo, T., Ayoub, W. S., Galloway, C., Christianson, A. L., Nissen, N. N.> ;Transplantation proceedings. 2018 Dec 24
• Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
  Kim, T. H., Yang, Y. M., Han, C. Y., Koo, J. H., Oh, H., Kim, S. S., You, B. H., Choi, Y. H., Park, T., Lee, C. H., Kurose, H., Noureddin, M., Seki, E., Wan, Y. Y., Ch...> ;The Journal of clinical investigation. 2018 Oct 10
• GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
  Loomba, R., Kayali, Z., Noureddin, M., Ruane, P., Lawitz, E. J., Bennett, M., Wang, L., Harting, E., Tarrant, J. M., McColgan, B. J., Chung, C., Ray, A. S., Subramania...> ;Gastroenterology. 2018 Jul 31
• Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD).
  Noureddin, M., Loomba, R.> ;Alimentary pharmacology & therapeutics. 2018 Jul 13
• Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.
  Mayo, R.,Crespo, J.,Martínez-Arranz, I.,Banales, J. M.,Arias, M.,Mincholé, I.,Aller de la Fuente, R.,Jimenez-Agüero, R.,Alonso, C.,de Luis, D. A.,Vitek, L.,Stritesky, ...> ;Hepatol Commun. 2018 Jul 22
• NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
  Noureddin, M., Vipani, A., Bresee, C., Todo, T., Kim, I. K., Alkhouri, N., Setiawan, V. W., Tran, T. T., Ayoub, W. S., Lu, S. C., Klein, A. S., Sundaram, V., Nissen, N...> ;The American journal of gastroenterology. 2018 Jun 9
• Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
  Liu, T., Yang, H., Fan, W., Tu, J., Li, T. W., Wang, J., Shen, H., Yang, J., Xiong, T., Steggerda, J., Liu, Z., Noureddin, M., Maldonado, S. S., Annamalai, A., Seki, E...> ;Gastroenterology. 2018 May 8
• Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
  Sundaram, V., Jalan, R., Ahn, J. C., Charlton, M. R., Goldberg, D. S., Karvellas, C. J., Noureddin, M., Wong, R. J.> ;Journal of hepatology. 2018 May 2
• Role of Aramchol in steatohepatitis and fibrosis in mice.
  Iruarrizaga-Lejarreta, M.,Varela-Rey, M.,Fernández-Ramos, D.,Martínez-Arranz, I.,Delgado, T. C.,Simon, J.,Juan, V. G.,delaCruz-Villar, L.,Azkargorta, M.,Lavin, J. L.,M...> ;Hepatol Commun. 2017 Nov 22
• The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
  Shouhed, D., Steggerda, J., Burch, M., Noureddin, M.> ;Expert review of gastroenterology & hepatology. 2017 Jul 18
• Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort.
  Setiawan, V. W., Porcel, J., Wei, P., Stram, D. O., Noureddin, N., Lu, S. C., Le Marchand, L., Noureddin, M.> ;Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017 Mar 17
• 2 citations
  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
  Han, M. A., Saouaf, R., Ayoub, W., Todo, T., Mena, E., Noureddin, M.> ;Expert review of clinical pharmacology. 2017 Mar 10
• Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
  Alonso, C., Fernández-Ramos, D., Varela-Rey, M., Martínez-Arranz, I., Navasa, N., Van Liempd, S. M., Trueba, J. L., Mayo, R., Ilisso, C. P., de Juan, V. G., Iruarrizag...> ;Gastroenterology. 2017 Jan 31
• 1 citation
  Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
  Fan, W., Yang, H., Liu, T., Wang, J., Li, T. W., Mavila, N., Tang, Y., Yang, J., Peng, H., Tu, J., Annamalai, A., Noureddin, M., Krishnan, A., Gores, G. J., Martínez-C...> ;Hepatology (Baltimore, Md.). 2016 Dec 17
• Predictors of Mortality in the Critically Ill Cirrhotic Patient: Is the Model for End-Stage Liver Disease Enough?
  Annamalai, A., Harada, M. Y., Chen, M., Tran, T. T., Ko, A., Ley, E. J., Nuno, M., Klein, A. S., Nissen, N. N., Noureddin, M.> ;Journal of the American College of Surgeons. 2016 Nov 27
• Promising therapies for treatment of nonalcoholic steatohepatitis.
  Noureddin, M., Zhang, A., Loomba, R.> ;Expert opinion on emerging drugs. 2016 Aug 9
• 13 citations
  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.
  Noureddin, M., Anstee, Q. M., Loomba, R.> ;Alimentary pharmacology & therapeutics. 2016 Apr 12
• The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.
  Tana, M. M., Shums, Z., Milo, J., Norman, G. L., Leung, P. S., Gershwin, M. E., Noureddin, M., Kleiner, D. E., Zhao, X., Heller, T., Hoofnagle, J. H.> ;American journal of clinical pathology. 2015 Sep 20
• 11 citations
  Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
  Noureddin, M., Rotman, Y., Zhang, F., Park, H., Rehermann, B., Thomas, E., Liang, T. J.> ;Genes and immunity. 2015 May 29
• 20 citations
  Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
  Noureddin, M., Rinella, M. E.> ;Clinics in liver disease. 2015 Apr 30
• 13 citations
  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.
  Noureddin, M., Mato, J. M., Lu, S. C.> ;Experimental biology and medicine (Maywood, N.J.). 2015 Apr 16
• Join now to see all

Journal Articles

• NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.  
  Noureddin M1,2, Vipani A3, Bresee C4, Todo T5, Kim IK5, Alkhouri N6, Setiawan VW7, Tran T8,3, Ayoub WS8,3, Lu SC8,3, Klein AS5, Sundaram V8,3, Nissen NN5., American Journal of Gastrenterology, 6/8/2018